This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Karin Grosch
CMC Regulatory Affairs Director at AstraZeneca
Speaker

Profile

Karin Grosch is a CMC (Chemistry Manufacturing and Control) Regulatory Affairs Director at AstraZeneca, Sweden, with over 20 years of experience in the pharmaceutical industry. Throughout her career, Karin has held various roles in Quality and Regulatory Affairs. For the past 15 years, she has specialized in regulatory CMC requirements, focusing on marketing applications and post-approval submissions. Karin has a wide range of experience in the strategic aspects of global marketing applications and currently leads regulatory CMC activities for AstraZeneca's commercial oligonucleotide program. She holds a MSc in Pharmacy from Uppsala University, Sweden.

Agenda Sessions

  • Oligonucleotide Odyssey: Regulatory CMC Insights from Recent Global Filings

    11:15